Form 4 · Filed May 29, 2026, 09:05 PM UTC
IMMX/Immix Biopharma, Inc.
Adams Helen C. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 22, 2026 | A | other | 6,250 | $0 | — | 181,004 |
| May 22, 2026 | A | other | 12,500 | — | — | 12,500 |
Source: SEC EDGAR raw filing ↗ · Accession 0001493152-26-026429